Target intelligence / Profile preview

Solute carrier family 16 member 13 (SLC16A13 (also MCT13))

Target
SLC16A13 (also MCT13)
Molecular classification
Transporter, Solute carrier family, Monocarboxylate transporter
01

Overview

Solute carrier family 16 member 13 (SLC16A13, also known as monocarboxylate transporter 13 or MCT13) is a proton-linked transporter belonging to the SLC16 family of monocarboxylate transporters, responsible for transporting monocarboxylic acids such as lactate across cellular membranes[5][7]. It is an orphan transporter, meaning its full substrate profile and physiological functions are not completely characterized[6]. SLC16A13 is expressed in human tissues including the Golgi apparatus and cytosol, and is implicated in energy metabolism, particularly related to glucose and lipid regulation[2][4]. Genetic studies have linked SLC16A13 variants to increased susceptibility for type 2 diabetes and hepatic steatosis through effects on hepatic insulin sensitivity and lipid accumulation[2]. There are currently no established drugs directly targeting this transporter, and its precise role in disease and therapy remains under investigation[2][5][6][7].

Other names
Monocarboxylate transporter 13MCT13MOT13_HUMAN
02

Mechanism of action

Proton-linked transport of monocarboxylates (e.g., lactate, possibly others) across plasma membrane

03

Biological functions

Monocarboxylic acid transportTransmembrane transportCellular energy metabolismPossibly regulation of lipid and glucose homeostasis
04

Disease associations

Type 2 diabetesHepatic steatosis (fatty liver)Insulin resistance
05

Biomarkers

Genetic association (polymorphism) with type 2 diabetes risk

Beyond the preview

Go deeper on Solute carrier family 16 member 13 (SLC16A13 (also MCT13)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 16 member 13 (SLC16A13 (also MCT13)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call